Clinical Trial Update: Ondansetron in Treatment Resistant Obsessive Compulsive Disorder (OCD) [Phase 4]

View source ↗

Summary

Phase 4 trial evaluating ondansetron for treatment-resistant obsessive-compulsive disorder has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obsessive-compulsive Disorder

Drugs mentioned

• Ondansetron (ondansetron)

Snippet

Sponsor: Institute of Neuroscience, Florence, Italy | Conditions: Obsessive Compulsive Disorder | Phase 4 | Status: COMPLETED